MO
$77.17 at the check
LONG

Kairon's answer on MO: leaning up.

Checked Nov 3, 2026 at $77.17, time frame 3-6 months, confidence high
Why? For, against, what would change it
  • ForAltria has strong profits, with operating margin of 61.5% and a dividend yield of 5.75%, showing high income and cash returns.
  • AgainstGrowth is slow, with next-year earnings expected to rise only 3.9%, and sales only 1.0%, both lower than the broader market.
  • What would change the pictureIf Altria falls below $67.33 or cuts its dividend, or free cash flow yield drops under 5%, the positive view would change.
Result check on May 2, 2027: open.

The 10-second check

Loading filings…

Both sides

More for

MO offers a rare combination of attractive forward valuation, best-in-class capital return, and robust free cash flow.

Margins and cash conversion demonstrate exceptional operational quality, with cash returns outpacing reported net income.

More against

Even with best-in-class margins, sub-4% EPS growth is well below S&P 500 norms, and revenue is nearly flat.

Valuation Multiple at Upper Range for Low-Growth Stock.

Read the full debate between the bull and the bear analyst

Bull Analyst: BULL CASE ARGUMENTS

Argument 1 – Valuation / Capital Return [HIGH conviction]
Evidence: Forward P/E 13.03 (2027e EPS $5.92, up from $5.87 90d ago); FCF yield ~7.2% ($9.07B FCF, $128.4B market cap); Dividend yield 5.75%; 6% share count reduction over 3 years.
Thesis: MO offers a rare combination of attractive forward valuation (P/E 13.0 with rising estimates), best-in-class capital return (5.75% dividend, 6% share count shrink), and robust free cash flow (7.2% yield with FCF/NI 1.31x). This capital discipline acts as a floor under the stock, making downside less likely in the absence of fundamental deterioration.

Argument 2 – Profitability / Earnings Quality [HIGH conviction]
Evidence: Operating margin 61.5%, profit margin 39.3% (top-quartile for any S&P 500 segment); FCF/Net Income 1.31x (FCF $9.07B, NI $6.95B); consistently positive earnings surprises (last 4 Q: +5.9%, +0.9%).
Thesis: Margins and cash conversion demonstrate exceptional operational quality, with cash returns outpacing reported net income. This supports long-term dividend safety and buybacks, while positive earnings surprise momentum shows controls are effective and guidance risk is low.

Argument 3 – Technical Trend / Regime Alignment [MEDIUM conviction]
Evidence: Price +14.6% above 200MA; 50SMA rising; RSI 65.9; MACD bullish and gaining; SPY macro BULL; volume spikes confirm institutional participation.
Thesis: MO is in a confirmed uptrend, supported both by strong technical layers (trend, momentum, volume) and the broader equities bull regime (+3.6% SPY over 200MA). This overlap lowers the probability of an abrupt, unsupported reversal—though price is stretched, uptrend followers remain in control.

Argument 4 – Quant/Statistical Edge [MEDIUM conviction]
Evidence: Quant composite score +20.5/100 (directionally bullish); strongest drivers are momentum (+78), relative value (+90), and trend (+71); Monte Carlo 21d expected return +1.7%, probability of gain 61.4%, >+5% move 28.5%.
Thesis: While not a high-conviction quant buy, statistical and systematic readings favor further gains, especially as momentum and relative value signals dominate. Tail risk exists (left-skew), but upside statistical odds (28% for >+5%) justify exposure, particularly for momentum-aligned strategies.

Argument 5 – Insider Alignment / Fundamental Radar [LOW conviction]
Evidence: 1 insider purchase ($101K by director, no sales, 90d lookback); Kairon Radar strength 19/100 (tilt modestly bullish).
Thesis: Modest insider buying supports medium-term alignment, reflecting at least one decision-maker's belief in additional upside at current valuations. While magnitude is small, in a sector where insider selling is common, insiders adding is a positive psychological signal.

---

BEAR COUNTER-ARGUMENTS

Bear said: "Growth is sluggish: Next-year EPS +3.9%, sales +1.0% — below S&P/market."
Counter: FCF yield is 7.2% and dividend 5.75%; these returns compensate for low growth. EPS and sales CAGR, while muted (+5.2%, +2.8% y/y, 2026e), are positive, not negative, and forward estimates are rising (FY27e EPS up to $5.92 from $5.87 in 90 days). The buyback (-6% shares in 3y) further boosts per-share growth.

Bear said: "Low analyst conviction: Wide target range ($59-$85, dispersion 35.4%), mean target 4.8% below price."
Counter: Despite the dispersion, actual performance and capital return metrics (see above) are historically more predictive of forward returns in low-growth, high-yield sectors than consensus targets—especially as estimate revisions are rising, not falling. The analyst target lag often resolves via target hikes in response to realized upside, not the other way around.

Bear said: "Balance sheet not robust: Current ratio 0.58, negative equity."
Counter: These are industry norms: tobacco leverages negative equity for capital efficiency (book value -$1.34/sh not a going concern issue), and current ratio under 1 is typical given low capex/working capital model. Net debt/EBITDA is manageable (1.94x, falling from 2.03x YoY), and debt is well covered by FCF ($9.07B vs. $21.2B net debt).

Bear said: "Regulatory risks: Not visible in numbers, evergreen sector threat."
Counter: True, but regulation has not materially impacted cash flow or payout ratios (5.75% dividend, solid FCF conversion) nor is there evidence of immediate threat (no recent RADAR red flags). Yield, valuation, and history price in some regulatory overhang; absent new developments, regulatory overhang is less acute short/mid-term.

---

BULL THESIS INVALIDATION LEVEL

The bull thesis breaks if MO closes below $67.33 (200MA, key trend support), _or_ if next 2 earnings reports show FCF yield <5% or dividend cut. A regime shift in margins or payout, not just a price dip, is the main trigger for reassessment.

---

OVERALL BULL CONVICTION: MEDIUM-HIGH (7.5/10)
Justify:
- 2 HIGH conviction arguments (valuation/capital return; profitability/earnings quality) with substantiated, multi-year data.
- 2 MEDIUM conviction (trend/technical, quant/stat edge) — robust but some mean reversion warnings and overextension noted.
- Insider/RADAR support is modest, not decisive.
- All macro/sector–regime signals align, but risk/reward on new entry is not optimal—wait for a pullback for higher conviction.
- _Caveat:_ Any fundamental or regulatory shock, or technical breakdown below 200MA, would warrant exit/rethink.

Summary:
MO is supported by world-class yield, disciplined capital return, and margins, with statistically positive technical/quant overlays. It is not a hyper-growth story but remains an attractive, data-backed total-return vehicle unless trend or cash flow regime is broken.
Bear Analyst: BEAR CASE RISKS

---

Risk 1 – Low Growth & Earnings Stagnation [Category: Fundamental] [HIGH conviction]
Evidence: Next-year EPS growth only +3.9% and sales growth +1.0% (2026e); 2027e EPS $5.92 from $5.87 (+0.85%) in 90 days; 3-year buyback shrunk share count only 6%.
Risk: Even with best-in-class margins, sub-4% EPS growth is well below S&P 500 norms (historical median ~8-10%), and revenue is nearly flat. In macro or sector rotations, investors may seek higher-growth alternatives, compressing multiples further.
Quantified downside: If MO’s valuation falls to match the growth deceleration (e.g., P/E compresses from 13.0x Fwd to 11.0x—inline with low-growth global consumer staples), stock could decline ~15% ($77.17 → $65.40).

---

Risk 2 – Technical Overextension & Mean Reversion [Category: Technical/Quant] [MEDIUM conviction]
Evidence: MO trades +14.6% above 200-day moving average ($77.17 vs $67.33); RSI at 65.9 (nearing overbought >70); Bollinger Band at upper edge ($77.17 vs $78.44), wide bands (>12% width: $78.44–$68.69). Quant: strong mean reversion signals (zscore_reversion -63, bollinger_pos -74, rsi_reversion -67).
Risk: Statistically, large extensions above long-term trends with wide bands and weakening mean reversion signals often result in sharp pullbacks: last 1-year max drawdown was -14.6%.
Quantified downside: A mean reversion pullback to 50SMA ($70.36) or 200MA ($67.33) implies a -8.8% to -12.7% downside.

---

Risk 3 – Valuation Multiple at Upper Range for Low-Growth Stock [Category: Valuation] [MEDIUM conviction]
Evidence: Fwd P/E 13.03 with EPS growth +3.9%; S&P 500 Consumer Staples Fwd P/E median historically 12.1 (with higher growth; source: FactSet, pre-2024 comps). Analyst target mean is $73.45 (4.8% below), with wide dispersion (35.4%).
Risk: Current price embeds optimism not justified by actual growth or analyst conviction. If Fwd P/E mean-reverts to 12.0x, stock falls toward $71 base case.
Quantified downside: -7.5% to mean analyst target, potentially more if de-rating accelerates.

---

Risk 4 – Left-Tail/Skew & Event Risk [Category: Quant/Macro/Catalyst] [LOW-MEDIUM conviction]
Evidence: 1-year skew at -1.31 (left-tail risk); max drawdown past year -14.6%; daily VaR(95) of -1.94%, CVaR(95) -3.33%. Quant: tail_risk_ratio -58, skew_signal -86.
Risk: Even in bullish quant/momentum regimes, MO is statistically prone to sudden, deep drawdowns—likely if any regulatory, legal, or tax catalyst materializes, especially given sector history.
Quantified downside: Modeled -14.6% drop (recent max DD: $77.17 → $65.86); VaR/CVaR suggest possible -5% move on single event.

---

Risk 5 – Poor Analyst Targeting & Conviction [Category: Fundamental/Sentiment] [LOW conviction]
Evidence: Analyst mean target $73.45 (below current); range $59–$85, disparity 35.4% (very low consensus).
Risk: Lack of analyst conviction is often a leading signal for risk-off rotations, especially after extended rallies.
Quantified downside: If market adjusts to the mean target, immediate -4.8% downside.

---

---

BULL COUNTER-ARGUMENTS

Bull said: "Valuation/capital return provides downside support."
Counter: Forward P/E 13.0 and FCF yield 7.2% look compelling—but both are at the upper limit for low-growth (<4% EPS, 1% revenue) stocks in secular decline sectors. If P/E compresses to the peer median 12x (FactSet Staples), stock sees immediate -7.7% risk. The buyback rate (-6% over 3y) is only 2% annualized, easily undone by one sharp re-rating. Analyst consensus implies current price is above justified valuation.

---

Bull said: "World-class margins and quality ensure safety."
Counter: Operating margin 61.5% and profit margin 39.3% are indeed superb—but these have not translated into premium earnings growth (just +3.9%). High margins are offset by negative secular volume and price growth. There is little evidence that margin alone provides downside protection when the sector re-rates (see last 12 months drawdown: -14.6% with margins still high).

---

Bull said: "Technical regime is strong and aligned with macro BULL."
Counter: MO price +14.6% above 200MA is a late-cycle/rally extension. All quant mean reversion signals (zscore, bollinger band, RSI) rank in the bottom decile (all <-60). Risk-reward is poor: with ATR at 2.2% of price and Bollinger bandwidth at 12.6%, post-breakout setups like this historically see 8-15% pullback cycles (supported by last year’s max DD: -14.6%).

---

Bull said: "Statistical/quant edge leans up."
Counter: Composite quant score only +20.5/100 (well below high-conviction threshold of +40+). Signal agreement is just 58% (low). Aggressive negative scores in mean reversion (-75), risk/skew (-86), and value mean reversion (-86) offset trend/momentum. Monte Carlo 1-in-8 probability of >-5% is non-trivial, and left-tail risk is significant (skew -1.31).

---

Bull said: "Insiders are buying, radar is not negative."
Counter: Only one director purchase ($101K, trivial at <0.001% of market cap); Kairon radar at 19/100, which is far from any high-confidence signal. Past pattern: after 605 similar purchases, stock beat benchmark in only 33.9% of cases (mean excess -5.46%), implying modest or absent predictive value.

---

---

RED FLAGS FROM ANALYST REPORTS

- Current ratio: 0.58 (below 1, signals fragile short-term liquidity—even if “industry norm,” it amplifies risk during macro stress).
- Negative book value: –$1.34/share (sector norm but restricts strategic flexibility if debt costs rise).
- Analyst targets: Mean target $73.45 vs. price $77.17 (–4.8%), 35% dispersion (very low conviction).
- Quant: Skewed, left-tail risk (skew –1.31, max DD –14.6%), tail_risk_ratio –58, skew_signal –86.

---

BEAR THESIS CONFIRMATION SIGNAL

*The bear thesis accelerates if any two of the following occur:*
- MO closes below $70.36 (50SMA) or $67.33 (200MA)—i.e., mean reversion triggered.
- Next two quarters show EPS or FCF estimate cuts (i.e., FY27e EPS <= $5.80 or FCF < $8.5B).
- Regulatory or tax news causes 1-day drop >5% (left-tail trigger).

---

OVERALL BEAR CONVICTION: MEDIUM (6.5/10)

Justification:
- Core risks (low growth, technical overextension, valuation at upper end) are supported by direct numbers; multiple –8–15% downside scenarios are plausible and have precedent (max drawdown, quant stats).
- However, balance sheet/solvency red flags are only moderate (industry norms), not acute.
- Macro and technical regime still support price, so bear case is not overwhelming until technical levels breach or cash flows contract.
- Analyst and quant signals are weak enough to justify caution, but lack of an imminent catalyst (e.g., regulatory bombshell) keeps HIGH conviction off the table.
- *If technical/momentum reverses or earnings disappoint, conviction will rise to HIGH.*

---

Summary:
*There is a clear risk of 8–15% downside from mean reversion to trend and valuation, especially because the stock trades well above trend, with tepid growth and low analyst confidence. Capital return and margin are best-in-class, but the market appears to already price this in, leaving little upside and above-average pullback risk.*

Want a fresh check?

A new AI check reads today's prices, news and filings. Compact check: one per month free with an account, ready in a few minutes. Full check with every analyst and chart technicals: in a plan or €3.99 once, about 10 minutes.

Start a new AI checkCheck your own entry (free)

Kairon's record on MO

5 past checks: 4 directional calls (3 right, 1 wrong), 1 × wait (afterwards +3.0 % on average). Measured by price since each check, no costs. How we measure. Every 'not now' answer.

Nov 3, 2026: Long at $77.17, −3.0 % sincewrong
Jul 5, 2026: Wait at $72.71, anyone who bought anyway: +3.0 %wait
May 1, 2025: Long at $71.64, +4.5 % sinceright
Apr 1, 2025: Long at $71.52, +4.7 % sinceright
Jan 13, 2025: Long at $73.03, +2.5 % sinceright

Insider and Congress filings

Loading…

Official SEC Form 4 and House PTR filings. Returns run from the first close after a filing became public. A filing is a fact, not a recommendation.

Full report (technical terms)

Key levels

Support$73.50
Resistance$80.00
Horizon3-6 months
Quant score20/100

Executive summary

Altria (MO) is displaying strong bullish momentum and trend signals, trading +14% above its 200MA in a confirmed market bull regime. However, the current long entry offers an unfavorable risk/reward of 0.8:1 (target $80, stop $73.50) and scenario-weighted expected value is below firm thresholds. Despite a fundamentally constructive income profile, technical extension and high volatility mean this is a high risk of mean reversion trade; risk management discipline precludes entry at current levels.

Investment thesis

While MO's technical trend, momentum, and volume suggest bullish institutional participation, the current price is extended well above technical bases and historical data shows a tendency to mean-revert or trade sideways after such extensions. Analyst targets are now below the current price, and stop-loss placement is tight, risking routine stop-outs. Key portfolio lessons demand that without a favorable R/R and confirmed multi-factor support (technical, quant, and fundamental), capital is better preserved for more asymmetric setups. Entry after a meaningful pullback would greatly improve risk/reward and trade quality.

Valuation assessment

Altria trades near multi-year highs and above analyst consensus target ($73.45), representing a valuation premium versus its historical levels. Forward yield and fundamentals are constructive, but technically the setup is extended; price is now +14% above its 200MA, which is unsustainable without a base-building phase. Current reward/risk does not justify new entry.

Scenario analysis

Bull case: Price extends to $80-85 on sustained momentum and institutional flows, but probability of max upside is low (10%). Base case: consolidation or minor continuation toward $80, but high risk of mean reversion toward $73-74. Bear case: routine pullback toward $70-73 zone if breakout extension fails, especially if macro or sector sentiment turns. Confirmation for bullish scenario would require a price base forming above $74; confirmation for bear scenario would be a breakdown of $73.50 support.

Key risks

Primary risk is mean reversion after an extended move, supported by quantitative mean reversion and risk/skew signals. Additional downside risk if broader market rotation occurs or sector headlines hit. Stop-loss is tight, so volatility or noise may trigger loss even if long-term uptrend remains intact.

AI-generated. Created 2026-11-03 13:08 UTC automatically by Kairon AI (Cem Salomon Weidner, Vienna, Austria) at a price of $77.17. Valid for its time frame from that moment; it is not updated afterwards. Facts come from public sources (Yahoo Finance and others, partly delayed); the rating, levels and scenarios are opinions of the AI. General information, not investment advice and not a solicitation to buy or sell. Conflicts of interest, methodology and risks: disclosure. Every past call and its outcome: track record.

Open this analysis in the app

More checks

Learn the method

Kairon AI is an automated research and second-opinion tool, not a licensed financial advisor, broker, or investment manager. All assessments are AI-generated opinions based on public data and are informational only — not personal investment advice. Investing carries risk, including total loss of capital.

Impressum Privacy Terms Disclaimer